FDA PMA FDA Class 3 Approved 🇺🇸 United States

Shockwave Intravascular Lithotripsy System

PMA: P200039 · Supplement: S001 · Decision Apr 9, 2021
Classifications
1
FEI Numbers
8
Registration Numbers
8

Basic Information

Device Name
Shockwave Intravascular Lithotripsy System
Trade Name
Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter
PMA Number
P200039
Supplement Number
S001
Device Class
FDA Class 3
Product Code
QMG
Generic Name
Shockwave intravascular lithotripsy system
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
April 9, 2021
Date Received
March 10, 2021
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Postapproval Study Protocol
Expedited Review
N

Advisory Committee Statement

Approval for transition to continued follow up study.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QMG Shockwave Intravascular Lithotripsy System